Anemia and Blood Transfusion in Critically Ill Patients | Critical Care Medicine | JAMA | JAMA Network
[Skip to Navigation]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 35.175.212.130. Please contact the publisher to request reinstatement.
1.
von Ahsen N, Muller C, Serke S, Frei U, Eckardt KU. Important role of nondiagnostic blood loss and blunted erythropoietic response in the anemia of medical intensive care patients.  Crit Care Med.1999;27:2630-2639.Google Scholar
2.
Nelson AH, Fleisher LA, Rosenbaum SH. Relationship between postoperative anemia and cardiac morbidity in high-risk vascular patients in the intensive care unit.  Crit Care Med.1993;21:860-866.Google Scholar
3.
Hébert PC, Wells G, Tweeddale M.  et al. for the Transfusion Requirements in Critical Care (TRICC) Investigators and the Canadian Critical Care Trials Group.  Does transfusion practice affect mortality in critically ill patients?  Am J Respir Crit Care Med.1997;155:1618-1623.Google Scholar
4.
Rogiers P, Zhang H, Leeman M.  et al.  Erythropoietin response is blunted in critically ill patients.  Intensive Care Med.1997;23:159-162.Google Scholar
5.
Burnum JF. Medical vampires.  N Engl J Med.1986;314:1250-1251.Google Scholar
6.
Viljoen M, Coetzee IH, Roux JJ, Pretorius JP. Anemia in surgical intensive care patients.  Haematologica.1994;79:19-24.Google Scholar
7.
Groeger JS, Guntupalli KK, Strosberg M.  et al.  Descriptive analysis of critical care units in the United States: patient characteristics and intensive care unit utilization.  Crit Care Med.1993;21:279-291.Google Scholar
8.
Corwin HL, Parsonnet KC, Gettinger A. RBC transfusion in the ICU: is there a reason?  Chest.1995;108:767-771.Google Scholar
9.
Goodnough LT, Despotis GJ, Hogue Jr CW, Ferguson Jr TB. On the need for improved transfusion indicators in cardiac surgery.  Ann Thorac Surg.1995;60:473-480.Google Scholar
10.
Hébert PC, Wells G, Blajchman MA.  et al. for the Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group.  A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care.  N Engl J Med.1999;340:409-417.Google Scholar
11.
Brunson ME, Alexander JW. Mechanisms of transfusion-induced immunosuppression.  Transfusion.1990;30:651-658.Google Scholar
12.
Stevens CE, Aach RD, Hollinger FB.  et al.  Hepatitis B virus antibody in blood donors and the occurrence of non-A, non-B hepatitis in transfusion recipients: an analysis of the Transfusion-Transmitted Viruses Study.  Ann Intern Med.1984;101:733-738.Google Scholar
13.
Blumberg N, Heal JM, Murphy P, Agarwal MM, Chuang C. Association between transfusion of whole blood and recurrence of cancer.  Br Med J (Clin Res Ed).1986;293:530-533.Google Scholar
14.
Blumberg N, Heal JM. Immunomodulation by blood transfusion: an evolving scientific and clinical challenge.  Am J Med.1996;101:299-308.Google Scholar
15.
Marik PE, Sibbald WJ. Effect of stored-blood transfusion on oxygen delivery in patients with sepsis.  JAMA.1993;269:3024-3029.Google Scholar
16.
Vincent JL, Moreno R, Takala J.  et al.  The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure.  Intensive Care Med.1996;22:707-710.Google Scholar
17.
Gum PA, Thamilarasan M, Watanabe J, Blackstone EH, Lauer MS. Aspirin use and all-cause mortality among patients being evaluated for known or suspected coronary artery disease.  JAMA.2001;286:1187-1194.Google Scholar
18.
Rosenbaum PR, Rubin DB. Reducing bias in observational studies using subclassification on the propensity score.  J Am Stat Assoc.1984;79:516-524.Google Scholar
19.
Rubin DB. Estimating causal effects from large data sets using propensity scores.  Ann Intern Med.1997;127:757-763.Google Scholar
20.
Schallom L. Point of care testing in critical care.  Crit Care Nurs Clin North Am.1999;11:99-106.Google Scholar
21.
Silver MJ, Li YH, Gragg LA, Jubran F, Stoller JK. Reduction of blood loss from diagnostic sampling in critically ill patients using a blood-conserving arterial line system.  Chest.1993;104:1711-1715.Google Scholar
22.
Dale JC, Pruett SK. Phlebotomy—a minimalist approach.  Mayo Clin Proc.1993;68:249-255.Google Scholar
23.
Ania BJ, Suman VJ, Fairbanks VF, Rademacher DM, Melton III LJ. Incidence of anemia in older people: an epidemiologic study in a well defined population.  J Am Geriatr Soc.1997;45:825-831.Google Scholar
24.
Balducci L, Hardy CL. Anemia of aging: a model of erythropoiesis in cancer patients.  Cancer Control.1998;5:17-21.Google Scholar
25.
Jensen LS, Andersen AJ, Christiansen PM.  et al.  Postoperative infection and natural killer cell function following blood transfusion in patients undergoing elective colorectal surgery.  Br J Surg.1992;79:513-516.Google Scholar
26.
Jensen LS, Hokland M, Nielsen HJ. A randomized controlled study of the effect of bedside leucocyte depletion on the immunosuppressive effect of whole blood transfusion in patients undergoing elective colorectal surgery.  Br J Surg.1996;83:973-977.Google Scholar
27.
Tartter PI, Mohandas K, Azar P, Endres J, Kaplan J, Spivack M. Randomized trial comparing packed red cell blood transfusion with and without leukocyte depletion for gastrointestinal surgery.  Am J Surg.1998;176:462-466.Google Scholar
28.
Gott JP, Cooper WA, Schmidt FE.  et al.  Modifying risk for extracorporeal circulation: trial of four antiinflammatory strategies.  Ann Thorac Surg.1998;66:747-753.Google Scholar
29.
van de Watering LM, Hermans J, Houbiers JG.  et al.  Beneficial effects of leukocyte depletion of transfused blood on postoperative complications in patients undergoing cardiac surgery: a randomized clinical trial.  Circulation.1998;97:562-568.Google Scholar
30.
Gabriel A, Kozek S, Chiari A.  et al.  High-dose recombinant human erythropoietin stimulates reticulocyte production in patients with multiple organ dysfunction syndrome.  J Trauma.1998;44:361-367.Google Scholar
31.
van Iperen CE, Gaillard CA, Kraaijenhagen RJ, Braam BG, Marx JJ, van de Wiel A. Response of erythropoiesis and iron metabolism to recombinant human erythropoietin in intensive care unit patients.  Crit Care Med.2000;28:2773-2778.Google Scholar
32.
Corwin HL, Gettinger A, Rodriguez RM.  et al.  Efficacy of recombinant human erythropoietin in the critically ill patient: a randomized, double-blind, placebo-controlled trial.  Crit Care Med.1999;27:2346-2350.Google Scholar
Caring for the Critically Ill Patient
September 25, 2002

Anemia and Blood Transfusion in Critically Ill Patients

Author Affiliations

Author Affiliations: Department of Intensive Care, Erasme University Hospital, Brussels, Belgium (Drs Vincent and Peres-Bota); Department of Anesthesiology, Hôpital Broussais, Paris, France (Dr Baron); Department of Anesthesiology, Klinikum FSU Jena, Jena, Germany (Drs Reinhart and Meier-Hellmann); Istituto di Anestesia e Rianimazione, Ospedale Maggiore di Milano, Milan, Italy (Dr Gattinoni); Medical Intensive Care Unit, VU ziekenhuis, Amsterdam, the Netherlands (Dr Thijs); Department of Intensive Care, University College London Hospitals, London, England (Dr Webb); Department of Anesthesiology and Intensive Care, Onze Lieve Vrouwziekenhuis, Aalst, Belgium (Dr Nollet).

 

Caring for the Critically Ill Patient Section Editor: Deborah J. Cook, MD, Consulting Editor, JAMA.

JAMA. 2002;288(12):1499-1507. doi:10.1001/jama.288.12.1499
Abstract

Context Anemia is a common problem in critically ill patients admitted to intensive care units (ICUs), but the consequences of anemia on morbidity and mortality in the critically ill is poorly defined.

Objectives To prospectively define the incidence of anemia and use of red blood cell (RBC) transfusions in critically ill patients and to explore the potential benefits and risks associated with transfusion in the ICU.

Design Prospective observational study conducted November 1999, with 2 components: a blood sampling study and an anemia and blood transfusion study.

Setting and Patients The blood sampling study included 1136 patients from 145 western European ICUs, and the anemia and blood transfusion study included 3534 patients from 146 western European ICUs. Patients were followed up for 28 days or until hospital discharge, interinstitutional transfer, or death.

Main Outcome Measures Frequency of blood drawing and associated volume of blood drawn, collected over a 24-hour period; hemoglobin levels, transfusion rate, organ dysfunction (assessed using the Sequential Organ Failure Assessment score), and mortality, collected throughout a 2-week period.

Results The mean (SD) volume per blood draw was 10.3 (6.6) mL, with an average total volume of 41.1 (39.7) mL during the 24-hour period. There was a positive correlation between organ dysfunction and the number of blood draws (r = 0.34; P<.001) and total volume drawn (r = 0.28; P<.001). The mean hemoglobin concentration at ICU admission was 11.3 (2.3) g/dL, with 29% (963/3295) having a concentration of less than 10 g/dL. The transfusion rate during the ICU period was 37.0% (1307/3534). Older patients and those with a longer ICU length of stay were more commonly transfused. Both ICU and overall mortality rates were significantly higher in patients who had vs had not received a transfusion (ICU rates: 18.5% vs 10.1%, respectively; χ2 = 50.1; P<.001; overall rates: 29.0% vs 14.9%, respectively; χ2 = 88.1; P<.001). For similar degrees of organ dysfunction, patients who had a transfusion had a higher mortality rate. For matched patients in the propensity analysis, the 28-day mortality was 22.7% among patients with transfusions and 17.1% among those without (P = .02); the Kaplan-Meier log-rank test confirmed this difference.

Conclusions This multicenter observational study reveals the common occurrence of anemia and the large use of blood transfusion in critically ill patients. Additionally, this epidemiologic study provides evidence of an association between transfusions and diminished organ function as well as between transfusions and mortality.

×